Literature DB >> 29667068

Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma.

Bin Huang1,2, Therese A Dolecek3, Quan Chen2, Catherine R Garcia2, Thomas Pittman4,2, John L Villano5,6,7,8.   

Abstract

Radiation increases survival in glioblastoma (GBM); however, 30% do not receive this treatment. We sought to identify characteristics associated with not receiving radiation and the impact on outcomes. We analyzed the Surveillance, Epidemiology, and End Results program (SEER) 18 registries 2000-2013 research database on 30,479 GBM cases that were aged 20 years and older. In total, 21,179 received radiation as first course of therapy, while 8218 did not with 5178 (63%) being 65 years and older. Early decisions on surgery often predicted radiation therapy with 61% having only a biopsy or no surgery at diagnosis. Radiation use as upfront therapy has slowly increased over time at a rate of 0.4% per year; still 25% did not receive radiation in 2013. Cases treated with radiation were more likely to be younger, underwent surgery, lived in a metropolitan area, had higher socioeconomic status, and were in a couple-based relationship. An increased survival in GBM was associated with the use of upfront radiation along with younger age, being of race other than white, undergoing surgery, and a more recent diagnosis. Not receiving radiation therapy adversely affects survival. A trend toward an increased use of radiation was observed although many young adults still do not receive this treatment. Decreased usage of radiation in the elderly and in biopsy-only surgeries was anticipated, but race, gender, and poverty were also statistically significant. Clinicians should be aware of this underutilization, and an increased usage of radiation should improve outcomes for glioblastoma.

Entities:  

Keywords:  Disparity; Glioblastoma; Race; Radiation therapy; Surgery

Mesh:

Year:  2018        PMID: 29667068     DOI: 10.1007/s12032-018-1134-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

1.  Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Authors:  René-Olivier Mirimanoff; Thierry Gorlia; Warren Mason; Martin J Van den Bent; Rolf-Dieter Kortmann; Barbara Fisher; Michele Reni; Alba A Brandes; Jüergen Curschmann; Salvador Villa; Gregory Cairncross; Anouk Allgeier; Denis Lacombe; Roger Stupp
Journal:  J Clin Oncol       Date:  2006-06-01       Impact factor: 44.544

2.  Long-term survival of patients with glioblastoma multiforme (GBM).

Authors:  Nicolas R Smoll; Karl Schaller; Oliver P Gautschi
Journal:  J Clin Neurosci       Date:  2013-01-23       Impact factor: 1.961

3.  The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme.

Authors:  Sanjay Aneja; Dhruv Khullar; James B Yu
Journal:  J Neurooncol       Date:  2013-02-15       Impact factor: 4.130

4.  Survival outcomes in advanced laryngeal cancer.

Authors:  Uchechukwu C Megwalu; Andrew G Sikora
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-09       Impact factor: 6.223

5.  Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study.

Authors:  Patricia J Eifel; Alex Ho; Najma Khalid; Beth Erickson; Jean Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

6.  The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study.

Authors:  N Breen; M N Wesley; R M Merrill; K Johnson
Journal:  Ethn Dis       Date:  1999       Impact factor: 1.847

7.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 9.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

10.  Age disparity in palliative radiation therapy among patients with advanced cancer.

Authors:  Jonathan Wong; Beibei Xu; Heidi N Yeung; Eric J Roeland; Maria Elena Martinez; Quynh-Thu Le; Loren K Mell; James D Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.